Metabolic Mind

Starting college can change almost everything about your routine, including how, when, and what you eat. For students using ketogenic therapy as part of their mental health treatment, that transition can take some planning.In this interview, Dr. Bret Scher speaks with licensed mental health counselor Nicole Laurent about how students using ketogenic therapy with clinical support can navigate a college setting, where dining halls, dorm rooms, busy schedules, social events, and limited budgets can all affect food choices.Nicole shares practical ideas for:Keeping simple foods that support nutritional ketosis in a dorm roomMaking dining hall options workPlanning ahead for busy weeksUsing meal prep or delivery services strategicallyTalking with roommates and friends about dietary choicesAsking for support when staying consistent gets difficultThey also talk about the importance of paying attention to food quality. For students who are not using ketogenic therapy, reducing ultra-processed foods and eating more whole foods may still be a meaningful place to start.If ketogenic therapy is part of a student’s mental health care plan, the transition to college may require some adjustments. Planning ahead, building a support system, and working with an experienced care team can help students stay consistent as their routines and environment change.If you’re using ketogenic therapy for a psychiatric condition, work closely with an experienced healthcare provider before making treatment changes.👉 Looking for more back-to-school mental health resources for college students? Explore our Back to School blog for stories, science, and practical support for navigating campus life: https://www.metabolicmind.org/resources/library/blog/stories/back-to-school-metabolic-mental-health-guide/🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.🎙️ Take the Metabolic Mind Podcast Listener Survey for a chance to win! We’d love your feedback on what you’re enjoying, what you’d like to hear more of, and how we can make the podcast even more helpful. Complete the quick survey by September 15 for a chance to win a Metabolic Mind giveaway bundle featuring a Keto-Mojo meter, books from Dr. Chris Palmer and Dr. Georgia Ede, Metabolic Mind swag, and more. Winners will be notified September 18. Take the survey here: https://metmind.co/survey-youtubeNo purchase necessary. Open to U.S. residents and international participants 18+. Ends 9/15/26 at 11:59 PM PT. Void where prohibited.Expert Featured:Nicole Laurent, LMHChttps://x.com/KetoCounselorhttps://www.instagram.com/mentalhealthketo/https://mentalhealthketo.com/Resources Mentioned:Additional resourceshttps://mentalhealthketo.com/2025/04/17/dorm-room-keto-for-mental-health/Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

Do most people really need to eat less protein to live longer? In this episode of Metabolic Mind, Dr. Bret Scher responds to a new review getting attention for the claim that protein restriction may extend lifespan, and explains why that message can be misleading for older adults, active people, and anyone focused on metabolic health.Dr. Scher walks through the biology behind the headlines, including mTOR, FGF21, animal research, and the limits of applying rodent data directly to humans. He also explains why adequate protein becomes more important with age, especially for preserving muscle, reducing frailty risk, supporting insulin sensitivity, and maintaining independence.He covers:Why “eat less protein” headlines can miss important contextWhat mTOR and FGF21 have to do with protein restriction and longevityWhy rodent studies do not always translate cleanly to human healthHow sarcopenia and anabolic resistance change protein needs with ageWhy the protein RDA is a minimum, not a personalized target for health optimizationHow muscle supports glucose control and insulin sensitivityWhy protein needs depend on age, activity level, metabolic health, pregnancy, recovery, and training statusHow exercise, fasting, and lower insulin may influence similar cellular pathways without sacrificing adequate proteinProtein needs are personal. A sedentary 35-year-old, a 70-year-old trying to preserve muscle, an athlete, and someone recovering from illness are not all aiming for the same target. Age, activity, metabolic health, and muscle goals should shape the conversation.🎙️ We want to hear from you! Take our quick podcast survey at the link and enter for a chance to win. No purchase necessary. Open to U.S. residents and international participants 18+. Ends 9/15/26 at 11:59 PM PT. Void where prohibited: https://metmind.co/survey-listeners👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter/🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.#MetabolicMind #KetogenicTherapy #ProteinNeedsExpert Featured:Bret Scher, MD - Baszucki Group Medical Director & Host of the Metabolic Mind Podcasthttps://www.linkedin.com/in/bret-scher-08baaa102/https://www.instagram.com/drscher858/?hl=enhttps://x.com/bschermdResources Mentioned:The hallmarks of protein and amino acid restriction in aging and longevityhttps://www.cell.com/cell-press-blue/fulltext/S3051-3839(26)00077-0Free CME Clinician Trainings:Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits: https://www.metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-ytFollow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

How can clinicians use real-world patient data to personalize metabolic health care? In this episode of Metabolic Mind, Dr. Bret Scher speaks with Dr. Jeff Pua, an internal medicine and obesity medicine physician, about obesity medicine, metabolic syndrome, nutritional ketosis, and what clinicians can learn from patient outcomes in everyday practice.Dr. Pua shares how his approach has evolved from relying only on broad research categories to also paying close attention to individual patient experiments, blood tests, and lived experience. In his practice, he sees patients improve not only in weight and metabolic markers, but also in mood, mindset, mental sharpness, and confidence as they begin to see measurable changes in their own health.They cover:How obesity medicine is evolving beyond the number on the scaleWhy metabolic syndrome is a major focus in Dr. Pua’s practiceHow N-of-1 patient data can help clinicians personalize careWhat blood tests can reveal about real-world metabolic improvementWhy nutritional ketosis can be a helpful benchmark for some patientsHow nutrition, physical activity, and behavior change work togetherWhy exercise may become more accessible once metabolic health improvesThis conversation offers a clinician’s view of how metabolic health care can become more personalized, measurable, and empowering for patients.👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter/🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.#MetabolicMind #KetogenicTherapy #ObesityMedicineExpert Featured:Dr. Jeffrey Puahttps://www.drjeffreypuamd.com/https://www.instagram.com/drjeffreypuamd/http://linkedin.com/in/jeffrey-pua-a15627317Free CME Clinician Trainings:Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits: https://www.metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-ytFollow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

Could GLP-1 medications play a role in treating bulimia or binge eating disorder? In this episode of Metabolic Mind, Dr. Bret Scher speaks with Paige Gordon and psychiatrist Dr. Michael Lutter about Paige’s personal experience using a GLP-1 medication for treatment-resistant bulimia, and why researchers are beginning to explore the neurobiology of binge eating.Paige shares how years of therapy and medication never quieted the overwhelming binge urges that drove her bulimia. After hearing someone describe their experience on a podcast, she began exploring GLP-1 medication and saw a profound change in her urges and eating patterns. Dr. Lutter adds the scientific context, including genetic findings that may help explain why some people with binge eating or bulimia respond strongly to GLP-1 medications.They cover:How Paige’s bulimia began and why standard treatments didn’t fully helpWhat “food noise” felt like in her lived experienceWhy GLP-1 medications may affect appetite, reward pathways, and binge urgesHow genetics may help identify who responds to GLP-1sWhy eating disorder treatment needs more precision-focused researchThe risks of using GLP-1 medications in people with restrictive eating disordersWhy stigma keeps many people from discussing this treatment openlyThis conversation explores an emerging area of eating disorder research with hope, caution, and a clear need for larger clinical trials.👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter/🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.#MetabolicMind #GLP1 #EatingDisorderTreatmentExpert Featured:Paige Gordonhttps://paigegordonauthor.com/https://www.instagram.com/paigegordonauthor/https://www.linkedin.com/in/paigegordon/https://www.tiktok.com/@paigegordonauthorDr. Michael Lutterhttps://precision-psychiatry.com/https://www.linkedin.com/in/michaelluttermd/https://www.youtube.com/@precisionpsychiatryFree CME Clinician Trainings:Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits: https://www.metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-ytFollow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

Do GLP-1 medications improve metabolic health as much as they support weight loss? A new observational study in the Annals of Internal Medicine raises an important question about semaglutide, insulin discontinuation, type 2 diabetes, and what meaningful metabolic improvement may require.In this episode of Metabolic Mind, Dr. Bret Scher breaks down a real-world study of more than 9,000 veterans with type 2 diabetes who were using insulin and then added either a GLP-1 receptor agonist, SGLT2 inhibitor, or DPP4 inhibitor. Despite semaglutide’s stronger association with weight loss, the study found similar insulin discontinuation rates across all three groups over three years.Dr. Scher covers:Why weight loss and metabolic health improvements may not always move togetherWhat insulin discontinuation can reveal about insulin resistance and beta cell functionWhy semaglutide did not outperform older diabetes medications in this studyThe limitations of observational research and real-world medication dataHow GLP-1 medications and therapeutic carbohydrate reduction may work through complementary mechanismsWhy combining GLP-1s with therapeutic carbohydrate reduction may be an important area for future research and clinical practiceThis conversation takes a closer look at what metabolic health means, and why the path from weight loss to insulin independence may be more complex than the scale alone can show.👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter/🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.#MetabolicMind #KetogenicTherapy #GLP1Expert Featured:Bret Scher, MD - Baszucki Group Medical Director & Host of the Metabolic Mind Podcasthttps://www.linkedin.com/in/bret-scher-08baaa102/https://www.instagram.com/drscher858/?hl=enhttps://x.com/bschermdResources Mentioned:Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulationhttps://www.acpjournals.org/doi/10.7326/ANNALS-25-05216Free CME Clinician Trainings:Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits: https://www.metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-ytFollow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

What does it look like to put bipolar II disorder into remission and become a voice of hope for others living with serious mental illness? Robyn Dobbins joins Hannah Warren from Metabolic Mind to reflect on how ketogenic therapy transformed her life, and what it was like to see her own story featured in The Cholesterol Code documentary.In this conversation, you'll learn:What it was like for Robyn to see her personal story on the big screenWhy she has always been open about her mental health journey, even at the time of her bipolar II diagnosisHow her psychiatric symptoms showed up before ketogenic therapy, including persistent anger, exhaustion, and the urge to escape her own lifeWhat changed once she began ketogenic therapy and how her day-to-day experience shiftedWhy she continues to advocate for awareness around metabolic therapies for mental illnessHow The Cholesterol Code documentary could expand awareness of ketogenic therapy beyond current circlesWhat inspires Robyn to keep sharing her story and how she hopes it reaches others still sufferingRobyn's openness about her journey is helping break the stigma around serious mental illness and expand awareness of what recovery can look like.🎥 Watch The Cholesterol Code documentary and join the conversation shaping the future of metabolic health: https://www.youtube.com/watch?v=57Z8bUb1P94🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.#MetabolicPsychiatry #KetogenicTherapy #MetabolicMind #BipolarDisorderExpert By Experience Featured:Robyn Dobbinshttps://x.com/robynrdobbinshttps://www.facebook.com/people/Robyn-R-Dobbins/100090891465253/https://www.linkedin.com/in/robyn-dobbins-59bb1653/https://www.instagram.com/robynrdobbins/Free CME Clinician Trainings:Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits: https://www.metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-ytFollow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.*Disclaimer: Tapering psychiatric medication isn’t the goal for everyone, and adjusting doses too quickly can be dangerous. Medications should never be stopped abruptly, and changes should always be made with your prescriber.Visit Inner Compass Initiative [https://www.theinnercompass.org/] for more information on safe tapering.

Could metabolic therapies become part of the future of cancer care?That question sits at the center of Dr. Bret Scher’s conversation with neurologist and researcher Dr. Matthew Phillips, whose recent study explored a metabolic approach in people with glioblastoma, one of the most aggressive forms of brain cancer.Rather than relying on a single intervention, the study combined a ketogenic diet, intermittent fasting, and repeated five-day fasts alongside standard chemotherapy and radiation. Together, these strategies were designed to lower the Glucose Ketone Index, or GKI, by reducing glucose and increasing ketones.In this conversation, they explore:Why cancer cell metabolism is becoming an important area of researchHow glucose, ketones, and mitochondrial function may influence cancer growthWhy the GKI was a central target in the studyHow fasting and ketogenic therapy were integrated with standard cancer treatmentThe difference between intentional weight loss and cancer cachexiaWhy quality of life deserves as much attention as survivalWhat the study’s long-term survivors may teach researchersWhy larger randomized trials are still neededParticipants following the metabolic protocol achieved an average GKI of 1.88, and every participant completed all eight five-day fasts. The metabolic therapy group also had a median survival of 21 months compared with 14 months in the control group, along with a higher rate of survival beyond three years.These results offer a compelling reason to keep studying this approach, particularly in a cancer with such limited treatment options and a difficult prognosis. Since the trial was small and nonrandomized, it can’t provide definitive answers, but it does give researchers a strong foundation to build on.👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter/🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.#MetabolicMind #KetogenicTherapy #FoodAsMedicineExpert Featured:Dr. Matthew Phillipshttps://www.metabolicneurologist.com/https://x.com/drmclphillipsResources Mentioned:Intensive multimodal ketogenic metabolic therapy in glioblastoma: A clinical trialhttps://doi.org/10.1093/noajnl/vdag165Free CME Clinician Trainings:Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits: https://www.metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-ytFollow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

Do GLP-1 medications like Ozempic reduce physical activity? Preliminary research suggests they might, raising important questions about how exercise should be supported alongside treatment.GLP-1 medications are helping many people achieve meaningful weight loss and metabolic improvements. At the same time, findings presented at the Endocrine Society’s annual meeting showed declines in daily steps and moderate-to-vigorous activity after treatment began. In this video, Dr. Bret Scher examines those results, explores why activity levels may fall, and explains how similar concerns can arise with medications such as statins and antipsychotics.He covers:What the study found about physical activityWhy side effects and rapid weight loss may reduce movementHow muscle loss can affect long-term metabolic healthWhy resistance training and protein intake matterHow clinicians can provide more structured exercise supportThese findings highlight the importance of pairing GLP-1 medications with proactive support for physical activity and muscle preservation. More broadly, they suggest that when a treatment can affect appetite, energy, or body composition, those effects should be monitored and addressed as part of ongoing care.👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter/🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.#MetabolicMind #KetogenicTherapy #GLP1Expert Featured:Bret Scher, MD - Baszucki Group Medical Director & Host of the Metabolic Mind Podcasthttps://www.linkedin.com/in/bret-scher-08baaa102/https://www.instagram.com/drscher858/?hl=enhttps://x.com/bschermdFree CME Clinician Trainings:Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits: https://www.metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-ytFollow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

What does it take to truly understand and assess cardiovascular risk in modern medicine?Dr. Bret Scher joins Dr. Ford Brewer at the Collaborative Science (CoSci) conference to discuss the recent screening of The Cholesterol Code documentary and the bigger picture of metabolic health, cardiac imaging, and the future of risk assessment.In this conversation, you'll learn:Dr. Ford Brewer's reaction to The Cholesterol Code documentary and what stood out mostWhy metabolism, not just plumbing, drives cardiovascular diseaseHow CT angiogram with AI analysis is becoming the gold standard in cardiac imagingWhat CIMT (Carotid Intima-Media Thickness) measures and where it fits in evaluating riskWhy calcium scores can miss important soft plaqueWhat to look for when seeking a high-quality CIMT scanDr. Brewer's personal story of being diagnosed with manic depression in medical school and how lifestyle and metabolic changes shaped his journeyWhy GLP-1 medications, when used responsibly, can be a useful tool rather than a stand-alone solutionHow the overuse of statins and GLP-1s reflects broader issues in modern medicineThis discussion captures the value of bringing nuanced, individualized thinking into the conversation around cardiovascular risk, metabolic health, and mental wellness.🔎 Learn more about CIMT tests on our blog: Early Heart Disease Detection? Why You May Consider a CIMT Test🎥 Watch The Cholesterol Code documentary and join the conversation shaping the future of metabolic health: https://www.youtube.com/watch?v=57Z8bUb1P94#MetabolicMind #KetogenicTherapy #HeartDiseaseExpert Featured:Dr. Ford Brewerhttps://prevmedhealth.com/https://www.youtube.com/channel/UCmoEsq6a6ePXxgZeA4CVrUwhttps://www.instagram.com/brewer.fordhttps://www.linkedin.com/in/fordbrewer/https://www.facebook.com/DrFordBrewer/Free CME Clinician Trainings:Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits: https://www.metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-ytFollow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.